Shawnte Mitchell

SVP, GC and Corporate Affairs, Aptevo Therapeutics Inc.

Companies

Olema Pharmaceuticals, Inc.General counsel Feb 28, 2025 to now¹
Zogenix (United States)EVP, GC and Secretary Apr 21, 2020 to Mar 9, 2022²
Aptevo Therapeutics Inc.SVP, GC and Corporate Affairs Aug 10, 2018 to Mar 19, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zogenix (United States)0 shares⁴Mar 7, 2022
Olema Pharmaceuticals, Inc. OLMA0 shares⁵Mar 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 4, 2026Sold 233 shares at $24.69 of Olema Pharmaceuticals, Inc.⁵
Mar 4, 2026Sold 24,767 shares at $24.25 of Olema Pharmaceuticals, Inc.⁵
Mar 4, 2026Exercised options 25,000 shares at $4.37 of Olema Pharmaceuticals, Inc.⁵
Mar 3, 2026Sold 15,000 shares at $23.01 of Olema Pharmaceuticals, Inc.⁵
Mar 3, 2026Exercised options 15,000 shares at $4.37 of Olema Pharmaceuticals, Inc.⁵
Mar 7, 2022U 605 shares of Zogenix (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROlema Pharmaceuticals, Inc., General counsel
2
SEC EDGARZogenix (United States), EVP, GC and Secretary
3
SEC EDGARAptevo Therapeutics Inc., SVP, GC and Corporate Affairs
4
SEC EDGARZogenix (United States) shares after the filing of Mar 7, 2022
5
SEC EDGAROlema Pharmaceuticals, Inc. shares after the filing of Mar 4, 2026